Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
Phase of Trial: Phase III
Latest Information Update: 16 Sep 2016
Price : $35 *
At a glance
- Drugs Gemigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors LG Life Sciences
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
- 09 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Dec 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.